Viewing Study NCT04569032

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 9:54 PM

Ignite Modification Date: 2025-12-25 @ 7:33 PM

Study NCT ID: NCT04569032

Status: ACTIVE_NOT_RECRUITING

Last Update Posted: 2025-09-12

First Post: 2020-09-23

Is NOT Gene Therapy: False

Has Adverse Events: True

Brief Title: A Study of Brentuximab Vedotin and CHP in Frontline Treatment of PTCL With Less Than 10% CD30 Expression

Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module